GTLS vs MRNA · rev $4.26B vs rev $145.0M
Chart Industries Inc (GTLS) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Chart Industries Inc (GTLS) is a specialty industrial machinery company listed on NYSE.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported GTLS revenue for 2025-12-31 was $4.26B. Net income was $40.7M. Revenue was up 2.5% from 2024-12-31 to 2025-12-31. GTLS currently screens at market cap $9.90B.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
GTLS currently screens at market cap $9.90B. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the GTLS and MRNA stock pages for the full models.
Not investment advice.